Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 10/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 7/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30360548 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL30360545 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL30360547 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL30360546 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL2818009 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL8907835 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL30360543 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL8310250 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL10417162 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 | |
| SCHEMBL3041624 | 1.00 | FDPS (0.77) | FDPSMAPTSMN1; SMN2LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023046766-A1 | NOVEL SULFONATE COMPOUNDS | KARL FRANZENS UNIVERSITÄT GRAZ (AT) | 2023-03-30 | — | — | WO | disclosed |
| EP-1265483-B1 | USE OF PHENYLETHYLAMINE DERIVATIVES FOR THE ANITMICROBIAL TREATMENT OF SURFACES | CIBA SC HOLDING AG (CH) | 2006-03-29 | — | — | EP | disclosed |
| US-6846492-B2 | Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-01-25 | — | — | US | disclosed |
| US-20040006061-A1 | Alkoxybenzylamine | CIBA SPECIALTY CHEMICALS CORP. | 2004-01-08 | — | — | US | disclosed |
| US-20030207884-A1 | Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces | CIBA SPECIALTY CHEMICALS CORP. | 2003-11-06 | — | — | US | disclosed |
| EP-1300402-A1 | Alkoxybenzylamines with antimicrobial properties | Ciba SC Holding AG (CH) | 2003-04-09 | — | — | EP | disclosed |
| EP-1265483-A2 | USE OF PHENYLETHYLAMINE DERIVATIVES FOR THE ANITMICROBIAL TREATMENT OF SURFACES | Ciba SC Holding AG (CH) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001062082-A2 | USE OF PHENYLETHYLAMINE DERIVATIVES FOR THE ANITMICROBIAL TREATMENT OF SURFACES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-08-30 | — | — | WO | disclosed |
| EP-1004623-A1 | Aryl thioacetals useful as stabilizers in polymeric materials | GREAT LAKES CHEMICAL CORPORATION (US) | 2000-05-31 | — | — | EP | disclosed |
| US-4598150-A | Chromogenic 1-(3-methoxy-4-alkoxyphenyl)-2-(2'-quinolyl)ethylene compounds | YAMADA CHEMICAL CO. LTD (JP) | 1986-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207884-A1 | Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces | CLTC, TUBA3C, AOC1 | FDPS 3950/4885MAPT 4834/4885SMN1; SMN2 4757/4885 |
| US-20040006061-A1 | Alkoxybenzylamine | CLTC, CBR1, DDC | FDPS 4788/4885MAPT 4827/4885SMN1; SMN2 4447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.